Download HERE

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Multiple Sclerosis
Peterson LK, Fujinami RS. Inflammation, demyelination,
neurodegeneration and neuroprotection in the pathogenesis of
multiple sclerosis.(2007) J Neuroimmunol 184:37Y44
Jonathan L. McQualter and Claude C. A. Bernard Multiple sclerosis: a battle
between destruction and repair. (2007)
Journal of Neurochemistry,100, 295–306
Dutta,R and Trapp B. Pathogenesis of axonal and neuronal damage in MS (2007)
Neurology 68 (Supl 3) S22-31
Parkinson’s Disease
Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, et al. 2003. Staging of
brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24:197–
211
Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB. 2007.
Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo. J. Neurosci.
27:3338–46
Surmeier DJ. 2007. Calcium, ageing, and neuronal vulnerability in Parkinson’s
disease. Lancet Neurol.6:933–38
Waxman EA, Giasson BI. 2009. Molecular mechanisms of α-synuclein
neurodegeneration. Biochim.Biophys. Acta 1792:616–24
Alzhiemer’s Disease
Verena H. Finder Alzheimer’s Disease: A General Introduction
and Pathomechanisms (2010)
Journal of Alzheimer’s Disease 22 Sup. 5–S19
Li M, Chen L, Lee DH, Yu LC, Zhang Y (2007) The role
of intracellular amyloid beta in Alzheimer’s disease. Prog Neurobiol 83, 131-139
Cedaz0-Minguez,,A. (2007) Apolipoprotein E and Alzheimer’s Disease: molecular
mechanisms and therapeutic opportunities. J Cell Mol. Med 11, 1227-1238.
Pritchard,S et al. The toxicity of tau in Alzheimer’s Disease: turnover, targets and
potential therapeutics. (2011) J Cell Mol. Med. 15, 1621-1635
Hermes,M. Eichhoff,G and Garascchuk, O. (2010) Intracellular calcium signalling in
Alzheimer’s disease. J Cell. Mol. Med. 14, 30-41
Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N
Engl J Med 362, 329344.
General
Dobson CM (2003) Protein folding and misfolding. Nature
426, 884890.
Moreno,J.A.et al (2012) Sustained translational suppression by elF2a-P mediates
prion neuro degeneration. Nature 485(7399) 507-511 doi::10.1038/nature11058
Related documents